(PharmaNewsWire.Com, May 01, 2017 ) Middle-East and Africa Influenza Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 6.75% to reach USD 0.25 billion by 2021, from USD 0.18 billion in 2016.
Influenza or flu is a transmittable respiratory disease which affects throat, nose and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be pandemic, seasonal or zoonotic. Influenza can be lethal if goes unnoticed and is considered as a major reason of mortality, globally. Some of the symptoms of influenza are cough, fever, runny or stuffy nose, sore throat, headache, fatigue, and body ache. Children below 2 years of age and elderly above 65 years of age are at vulnerable of developing chronic flu. Within Middle-East & Africa, Egypt has been worst affected by Influenza A (H5N1) in 2015.
Key factors which affect and thereby cause changes to the market dynamics are studied essentially and are presented in a well-known way in the report. Some of those factors are Increasing public awareness and improve healthcare expenditure Cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. A large section of population in the region are not immunized against influenza virus Antigenic shift of influenza virus, shortage of cold storage facility, and remote areas with limited accessibility.
For granular level understanding the Influenza Market is segmented based on Product Type, Type, Application and Disease Indications, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Product Type: Introduction Vaccines Drugs Y-o-Y Growth Analysis, By Product Market Attractiveness Analysis, By Product Market Share Analysis, By Product Based on Type: Introduction Safety Biomarkers Efficacy Biomarkers Validation Biomarkers Y-o-Y Growth Analysis, By Type Market Attractiveness Analysis, By Type Market Share Analysis, By Type Based on Application: Introduction Diagnostics Development Drug Discovery and Development Personalised Medicine Disease Risk Assessment Other Applications Y-o-Y Growth Analysis, By Application Market Attractiveness Analysis, By Application Market Share Analysis, By Application Based on Disease Indications: Introduction Cancer CardiovascularDisorders Neurological Disorders Immunological Disorders Other Diseases Y-o-Y Growth Analysis, By Disease Indications Market Attractiveness Analysis, By Disease Indications Market Share Analysis, By Disease Indications
On the basis of geographical areas, Middle-East and Africa market for Influenza Market is segmented into Middle-East region and Africa region. Some of the key players that operate in the Middle-East and Africa Influenza Market include AstraZeneca (United Kingdom), Sanofi-Pasteur (U.S.), Novartis (Switzerland), F. Hoffmann-La Roche (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline (U.K.), Abbott Laboratories (U.S.), Merck & Co. (U.S.), CSL Limited (Australia) and Mitsubishi Tanabe Pharma Corporation (Japan).
Annually, nearly half-million people die of influenza and, with the threat of an epidemic in any given year, disease prevention organizations and government agencies are dedicated to gaining control of the situation. Many companies have been requested aid with the problem and others are furthering their position with backing from government agencies," notes Fitzgerald. The next five years should see funding and support for many product development, pandemic prevention and research and development programs and/or control by worldwide governments, health professionals and organizations.
The Middle-East and Africa Influenza Market report offers wide-range of scope: Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole Know more about key areas of industry growth via detailed Segment-level analysis on basis of Product Type, Type, Application and Disease Indications along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Pharmaceuticals Market:
About Market Data Forecast: Market Data Forecast is one of the prominent market research companies which offers syndicated as well as customized research services to individual or corporate clients. Their syndicated research reports contain Market Sizing and forecasts for 5-year period with a niche level of segmentation providing you with more focused insights whereas the consult research services can fetch the distinctive data requirements at competitive industry costs. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: